Medicare Enrolled
Dr. Terry Wimpey, M.D.
Neurology · Athens, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wimpey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wimpey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wimpey
Dr. Terry Wimpey is a neurology specialist in Athens, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wimpey performed 2,162 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wimpey received a total of $4,766 from 58 pharmaceutical and/or device companies across 331 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wimpey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 19% volume in GA
$4,766 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,162
Medicare services
Top 19% in GA for neurology
Not available
Unique patients (not deduplicated)
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
609 | $24 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
462 | $84 | $315 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
210 | $119 | $431 |
| New patient office visit, complex (60-74 min) | 180 | $148 | $532 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
126 | $141 | $2,000 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
69 | $60 | $275 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
56 | $33 | $240 |
| Central motor stimulation test of legs This procedure involves placing skin electrodes on the body to measure how electrical signals travel through the central nervous system to the leg muscles. |
52 | $58 | $181 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
38 | $226 | $2,800 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
38 | $128 | $463 |
| EEG monitoring for coma or sleep This procedure measures brain wave activity to monitor patients who are in a coma or asleep. |
36 | $42 | $175 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
28 | $257 | $1,250 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
25 | $29 | $750 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $53 | $229 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
23 | $142 | $2,000 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
23 | $434 | $2,087 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $91 | $220 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
23 | $60 | $600 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
22 | $446 | $2,602 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $123 | $450 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
21 | $88 | $500 |
| MRI of head blood vessels without contrast An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye. |
16 | $151 | $2,000 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
13 | $41 | $500 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
12 | $24 | $175 |
| Placement of skin electrodes and measurement of stimulated sites in legs This procedure involves placing skin electrodes on the legs and measuring the sites where stimulation is applied. |
11 | $20 | $66 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,766
Total received (2018-2024)
Avg $681/year across 7 years
Top 37% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
331
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$867
2023
$1,295
2022
$467
2021
$633
2020
$383
2019
$551
2018
$571
Payments by company (2024)
UCB, Inc.
$92
Novartis Pharmaceuticals Corporation
$81
PFIZER INC.
$67
TG Therapeutics, Inc.
$49
Amgen Inc.
$43
HARMONY BIOSCIENCES LLC
$41
Octapharma USA, Inc.
$40
Biogen, Inc.
$39
BANNER LIFE SCIENCES, LLC
$37
Amneal Pharmaceuticals LLC
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Teva Pharmaceuticals USA, Inc.
$28
Eisai Inc.
$28
Marinus Pharmaceuticals, Inc.
$24
Janssen Pharmaceuticals, Inc
$23
Sumitomo Pharma America, Inc.
$21
ARGENX US, INC.
$21
Neurelis, Inc.
$21
Ipsen Biopharmaceuticals, Inc
$21
Lundbeck LLC
$20
CATALYST PHARMACEUTICALS, INC.
$20
ABBVIE INC.
$19
SCILEX PHARMACEUTICALS INC.
$19
MDD US Operations, LLC
$18
Alexion Pharmaceuticals, Inc.
$17
ANI Pharmaceuticals, Inc.
$16
Top 3 companies account for 27.7% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$464
UCB, Inc.
$428
Novartis Pharmaceuticals Corporation
$329
Sunovion Pharmaceuticals Inc.
$249
ABBVIE INC.
$220
Biogen, Inc.
$204
PFIZER INC.
$170
Harmony Biosciences LLC
$165
MDD US Operations, LLC
$156
Supernus Pharmaceuticals, Inc.
$142
Allergan Inc.
$141
Teva Pharmaceuticals USA, Inc.
$140
EMD Serono, Inc.
$132
Alexion Pharmaceuticals, Inc.
$107
Lundbeck LLC
$104
Amgen Inc.
$93
HARMONY BIOSCIENCES LLC
$91
Eisai Inc.
$85
GENZYME CORPORATION
$84
GE HEALTHCARE
$73
Lilly USA, LLC
$70
ARGENX US, INC.
$61
JAZZ PHARMACEUTICALS INC.
$59
Ipsen Biopharmaceuticals, Inc
$53
Greenwich Biosciences, Inc.
$50
TG Therapeutics, Inc.
$49
Marinus Pharmaceuticals, Inc.
$48
Amneal Pharmaceuticals LLC
$48
ACADIA Pharmaceuticals Inc
$45
Sumitomo Pharma America, Inc.
$45
Neurocrine Biosciences, Inc.
$42
Octapharma USA, Inc.
$40
Janssen Pharmaceuticals, Inc
$39
BANNER LIFE SCIENCES, LLC
$37
ANI Pharmaceuticals, Inc.
$36
Neurelis, Inc.
$36
Avanir Pharmaceuticals, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$30
SK Life Science, Inc.
$28
Horizon Therapeutics plc
$26
Scilex Pharmaceuticals Inc.
$24
MERZ NORTH AMERICA, INC.
$23
Amylyx Pharmaceuticals, Inc.
$22
Catalyst Pharmaceuticals, Inc.
$21
CATALYST PHARMACEUTICALS, INC.
$20
E.R. Squibb & Sons, L.L.C.
$19
SCILEX PHARMACEUTICALS INC.
$19
Allergan, Inc.
$18
Adamas Pharmaceuticals, Inc.
$16
Biohaven Pharmaceuticals, Inc.
$16
Currax Pharmaceuticals LLC
$16
Biohaven Pharmaceutical Holding Company Ltd.
$15
Aprecia Pharmaceuticals, LLC
$15
IMPEL PHARMACEUTICALS INC.
$14
US WorldMeds, LLC
$14
Impax Laboratories, Inc.
$13
Mallinckrodt Hospital Products Inc.
$12
AQUESTIVE THERAPEUTICS, INC.
$12
Top 3 companies account for 25.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · CREXONT · DAYBUE · DUOPA · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gocovri · HYQVIA · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · ONGENTYS · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · QULIPTA · RELYVRIO · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRAVATO · SYMPAZAN · Spritam · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XEOMIN · ZEPOSIA · ZTALMY · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
21
County median income
$52,267
Nearest hospital to ZIP centroid (approximate)
ST MARY'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wimpey is a clinical cardiology specialist, with above-average Medicare volume (top 19% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wimpey experienced with continuous intraoperative neurophysiology monitoring, remote?
Based on Medicare claims data, Dr. Wimpey performed 609 continuous intraoperative neurophysiology monitoring, remote services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wimpey receive payments from pharmaceutical companies?
Yes. Dr. Wimpey received a total of $4,766 from 58 companies across 331 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wimpey's costs compare to other neurologists in Athens?
Dr. Wimpey's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wimpey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Athens
Browse neurologists in Athens ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology